Dynavax Technologies Aktie

9,01 EUR +0,24 EUR +2,78 %

09:59:01

FSE

10,66 USD +0,23 USD +2,16 %

16.07.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.1,11 Mrd. EUR

KGV62,35Div. Rendite0,00%

WKNA12EV9

ISINUS2681582019

SymbolDVAX

Dynavax Technologies Aktien News

Sortieren:Datum Meistgelesen

11.06.25PR NewswireDynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

09.06.25PR NewswireDynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

04.06.25PR NewswireDynavax Comments on Glass Lewis Recommendation

WerbungDynavax Technologies-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

28.05.25PR NewswireDynavax to Present at William Blair's 45th Annual Growth Stock Conference

23.05.25PR NewswireLeading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

12.05.25PR NewswireDynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

10.05.25PR Newswire/C O R R E C T I O N -- Dynavax Technologies/

07.05.25PR NewswireDynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

06.05.25PR NewswireDynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

01.05.25PR NewswireDynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

29.04.25PR NewswireDynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

22.04.25PR NewswireDynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

17.04.25PR NewswireDynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

03.04.25PR NewswireDynavax Files Preliminary Proxy Statement

06.03.25PR NewswireDynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

25.02.25PR NewswireDynavax to Participate in Upcoming Investor Conferences

20.02.25PR NewswireDynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

19.02.25PR NewswireDynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

06.02.25PR NewswireDynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

27.01.25PR NewswireDynavax Advances Board Refreshment Program

13.01.25PR NewswireDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

26.11.24PR NewswireDynavax to Present at the 7th Annual Evercore HealthCONx Conference

11.11.24PR NewswireDynavax Announces $100 Million Accelerated Share Repurchase Program

07.11.24PR NewswireDynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

07.11.24PR NewswireDynavax Announces $200 Million Share Repurchase Program

29.10.24PR NewswireDynavax Adopts Limited-Duration Stockholder Rights Plan

24.10.24PR NewswireDynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

06.08.24PR NewswireDynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

23.07.24PR NewswireDynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

27.06.24PR NewswireDynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program

28.05.24PR NewswireDynavax to Present at Upcoming Investor Conferences

14.05.24PR NewswireDynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.

08.05.24PR NewswireDynavax Reports First Quarter 2024 Financial Results and Provides Business Updates

24.04.24PR NewswireDynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

28.02.24PR NewswireDynavax to Present at TD Cowen's 44th Annual Health Care Conference

22.02.24PR NewswireDynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance

08.02.24PR NewswireDynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024

08.01.24PR NewswireDynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

04.01.24PR NewswireDynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference

20.11.23PR NewswireDynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference

Dynavax Technologies News

Dynavax Technologies News: auf dieser Seite finden Sie alle Dynavax Technologies News und Nachrichten zur Dynavax Technologies Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Dynavax Technologies News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Dynavax Technologies News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.